First Patient Enrolled in Cook Regentec’s Clinical Trial of Investigational Therapy for Critical Limb Ischemia
![First Patient Enrolled in Cook Regentec’s Clinical Trial of Investigational Therapy for Critical Limb Ischemia](https://www.cookgroup.com/content/uploads/2019/09/HemaTrate-Filtration-System.png)
Study sites are currently being evaluated for enrollment in the US, Canada and the EU Indianapolis, Ind. – Cook Regentec today announced enrollment of the first patient in an international clinical trial evaluating the HemaTrate® Blood Filtration System to treat patients with critical limb ischemia (CLI) due to peripheral arterial disease (PAD). To treat CLI, […]